Neuromuscular Disorders

Neuromuscular disorders result in impaired functioning of the muscles. Discover the latest research on these disorders, including ALS, and the underlying genetic aspects here.

August 1, 2020

Split-finger syndrome in amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery, and Psychiatry
Masahiro SonooShunsuke Kobayashi
August 2, 2020

The glycomic sialylation profile of GNE Myopathy muscle cells does not point to consistent hyposialylation of individual glycoconjugates

Neuromuscular Disorders : NMD
Ilan SelaStella Mitrani-Rosenbaum
August 3, 2020
Review

Amyotrophic Lateral Sclerosis: Fuel for the Corticofugal Feud

Annals of Neurology
Brian J Wainger, Robert H Brown
August 1, 2020

Muscle strength and motor function in adolescents and adults with spinal muscular atrophy

Neurology
Camiel A WijngaardeW Ludo van der Pol
August 3, 2020
Review

Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases

European Journal of Pharmacology
Alexandra BouscaryJean-Philippe Loeffler
August 2, 2020

Evaluation and optimization of common lipid extraction methods in cerebrospinal fluid samples

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Bernd ReichlWolfgang Buchberger
July 31, 2020

Myoglobin: A new biomarker for spinal and bulbar muscular atrophy?

The International Journal of Neuroscience
Haixiao GuoXiaolu Liu
August 1, 2020

Facial nerve repair by muscle-vein conduit in rats: functional recovery and muscle reinnervation

Tissue Engineering. Part a
Maria Eleni ManthouDoychin Angelov
August 2, 2020

Preclinical Development of 18 F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-D-Aspartate Receptors and its Utility as a Biomarker for Amyotrophic Lateral Sclerosis

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Hazem AhmedSimon M Ametamey
July 31, 2020

Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing

American Journal of Human Genetics
Anna FliednerChristiane Zweier
July 31, 2020

UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis

Annals of Clinical and Translational Neurology
Ruibing LiChengbin Wang
July 30, 2020
Preprint

Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer

BioRxiv : the Preprint Server for Biology
H. StiresRebecca B. Riggins
July 31, 2020

Effect of Metatarsal Head Shape on the Development of Hallux Valgus Deformity: 10 Years of Natural Follow-up

Journal of the American Podiatric Medical Association
Ulunay KanatliMehmet Cetinkaya

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromuscular-disorders/e760a143-4ee5-4ad2-9672-c0bb792cc32c